{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:24:30Z","timestamp":1789885470858,"version":"4.0.1"},"reference-count":18,"publisher":"Informa UK Limited","issue":"10","funder":[{"name":"Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2016,10,2]]},"DOI":"10.1080\/13696998.2016.1187622","type":"journal-article","created":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T14:49:59Z","timestamp":1462546199000},"page":"965-972","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data"],"prefix":"10.1080","volume":"19","author":[{"given":"Chakkarin","family":"Burudpakdee","sequence":"first","affiliation":[{"name":"IMS Health, Fairfax, VA, USA;"},{"name":"University of North Carolina at Charlotte, Charlotte, NC, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huamao Mark","family":"Lin","sequence":"additional","affiliation":[{"name":"Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiying","family":"Wang","sequence":"additional","affiliation":[{"name":"NucleusX Market Access, Warren, NJ, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpamas","family":"Seetasith","sequence":"additional","affiliation":[{"name":"IMS Health, Fairfax, VA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayveer","family":"Bonthapally","sequence":"additional","affiliation":[{"name":"Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Carson","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,5,26]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2013.11.001"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-231548"},{"key":"CIT0004","unstructured":"Howlader N, Noone A, Krapcho M, et\u00a0al. SEER Cancer Statistics Review, 1975-2011. http:\/\/seer.cancer.gov\/csr\/1975_2011 (based on November 2013 SEER data submission, posted to the SEER website Apri 2014 Accessed March 31, 2015"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20999"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-09-3080"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-013-0232-x"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds643"},{"key":"CIT0009","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN clinical pracrtice guidelines in oncology: Non-Hodgkin's Lymphoma. Version 2. 2015 https:\/\/www.tri-kobe.org\/nccn\/guideline\/hematologic\/nhl\/english\/bcel.pdf [Accessed March 31, 2015]"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.7524"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1080\/10428190600573325"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","volume":"30","author":"d'Amore F","year":"2012","journal-title":"J Clin Oncol"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.5402\/2011\/623924"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-516245"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2014.911183"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.10.170"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-007-0131-1"},{"key":"CIT0018","unstructured":"Spectrum Pharmaceuticals Inc. BELEODAQ\u00ae (belinostat) for injection, for intravenous administration. Full prescribinginformation (July 2014). Spectrum Pharmaceuticals Inc., Handerson, NV, 2014 http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/206256lbl.pdf. Accessed March 31, 2015"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2016.1187622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T01:02:38Z","timestamp":1597712558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2016.1187622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,26]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10,2]]}},"alternative-id":["10.1080\/13696998.2016.1187622"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2016.1187622","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-09-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}